As part of the biological assessment of medical devices, we offer standardised analytical methods and customised studies for chemical characterisation of medical devices according to ISO 10993-18.
Analytical methods and concepts are in line with Extractables and Leachables studies for packaging materials and end products. In addition, rapid and cost-effective solutions are needed to compare medical devices after design and material changes, as well as after changes in starting materials, production batch or aging.
To achieve this, we use GC / HPLC / ICP fingerprinting, standardised analytical procedures taking into account existing material and manufacturing data, which leads to a complete chemical characterisation of medical devices.
In certain cases, a tailored study is recommended for a complete characterisation and safety assessment. Thanks to our expertise in both medical devices and pharmaceutical packaging, we are able to assist you in designing such a tailored study protocol (extraction temperature and duration, simulants used, etc.), which is required for the analytical evaluation of the extractables and their toxicological assessment.
We can support you with:
Extractable studies are performed through semi-quantitative methods. We set-up proposals based on the client’s needs and the specific scenario (extraction conditions, solvents, time, and temperature).
The extraction solutions will be analysed by different analytical techniques through quality-quantitative screening methods wherever applicable:
To better understand the safety profile of your medical devices, Eurofins Medical Device Testing network performs risk assessments and toxicological evaluations for you.
With the help of such a safety profile, additional analytical testing and biocompatibility testing can be scheduled. Furthermore, the safety profiles can be used in conjunction with the preclinical data for a comprehensive risk assessment.
These assessments are based on ISO 10993-17 and are used to identify and critically evaluate potential toxicities and exposures to humans. Both the final medical product and individual chemical compounds, additives, colourants, processing aids and potential extracts are considered.
If you would like to discuss your project and needs with our Business Development Manager Anja Kroon or request a quotation, feel free to contact us.
If you would like more information about our Medical Device testing capabilities, please also visit our global Medical Device website using the following link: https://www.eurofins.com/medical-device/